logo

EbookBell.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link:  https://ebookbell.com/faq 


We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.


For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookBell Team

Kinesins And Cancer 1st Edition Frank Kozielski Fsb Eds

  • SKU: BELL-5056938
Kinesins And Cancer 1st Edition Frank Kozielski Fsb Eds
$ 31.00 $ 45.00 (-31%)

5.0

80 reviews

Kinesins And Cancer 1st Edition Frank Kozielski Fsb Eds instant download after payment.

Publisher: Springer Netherlands
File Extension: PDF
File size: 8.57 MB
Pages: 271
Author: Frank Kozielski, FSB (eds.)
ISBN: 9789401797313, 9401797315
Language: English
Year: 2015
Edition: 1

Product desciption

Kinesins And Cancer 1st Edition Frank Kozielski Fsb Eds by Frank Kozielski, Fsb (eds.) 9789401797313, 9401797315 instant download after payment.

This interdisciplinary volume collates research work on kinesins and cancer. Authors attempt to validate members of the kinesin superfamily as potential targets for drug development in cancer chemotherapy. The work begins by highlighting the importance of kinesins, summarising current knowledge and how they are shown to be crucial for mitosis. Chapters go on to explore how this family of proteins are emerging as a novel target for chemotherapeutic intervention and drug development.

Readers will learn how kinesins travel along microtubules to fulfill their many roles in intracellular transport or cell division. Several compounds that inhibit two mitotic kinesins (called Eg5 and CENP-E) have entered Phase I and II clinical trials and are explored in these chapters. Additional mitotic kinesins are currently being validated as drug targets, raising the possibility that the repertoire of kinesin-based drug targets may expand in the future.

The book is suitable as a reference standard for the field of kinesins and cancer. It will interest those in academia and pharmaceutical companies, and anyone with an interest in the medical relevance of these proteins, which cutting edge methodologies are now enabling us to understand in astonishing detail.

Related Products